United States Antimony Corporation
United States Antimony Corporation (UAMY) Financial Performance & Income Statement Overview
Analyze United States Antimony Corporation (UAMY) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
United States Antimony Corporation (UAMY) Income Statement & Financial Overview
Access detailed annual and quarterly income data for United States Antimony Corporation UAMY financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $7.000M | $6.87M | $2.42M | $2.81M |
| Cost of Revenue | $4.63M | $5.32M | $2.00M | $1.91M |
| Gross Profit | $2.37M | $1.55M | $425768.00 | $908641.00 |
| Gross Profit Ratio | $0.34 | $0.23 | $0.18 | $0.32 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $932631.00 | $2.33M | $754655.00 | $698895.00 |
| Operating Expenses | $2.01M | $2.83M | $1.27M | $1.12M |
| Total Costs & Expenses | $6.64M | $8.15M | $3.27M | $3.03M |
| Interest Income | $192156.00 | $208014.00 | $157757.00 | $151921.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $763798.00 | $119584.00 | $132756.00 |
| EBITDA | $357992.00 | -$508034.00 | -$741711.00 | -$80848.00 |
| EBITDA Ratio | $0.05 | -$0.07 | -$0.31 | -$0.03 |
| Operating Income | $357992.00 | -$1.26M | -$845043.00 | -$213604.00 |
| Operating Income Ratio | $0.05 | -$0.18 | -$0.35 | -$0.08 |
| Other Income/Expenses (Net) | $188532.00 | $185715.00 | $161946.00 | $157900.00 |
| Income Before Tax | $546524.00 | -$1.08M | -$683097.00 | -$55704.00 |
| Income Before Tax Ratio | $0.08 | -$0.16 | -$0.28 | -$0.02 |
| Income Tax Expense | $0.00 | $0.00 | $44412.00 | $0.00 |
| Net Income | $546524.00 | -$882919.00 | -$727509.00 | $202792.00 |
| Net Income Ratio | $0.08 | -$0.13 | -$0.30 | $0.07 |
| EPS | $0.005 | $0.008 | -$0.007 | $0.002 |
| Diluted EPS | $0.004 | $0.008 | -$0.007 | $0.002 |
| Weighted Avg Shares Outstanding | $113.70M | $108.91M | $108.44M | $108.44M |
| Weighted Avg Shares Outstanding (Diluted) | $122.30M | $108.91M | $108.44M | $108.94M |
The company's financials show resilient growth, with revenue advancing from $2.81M in Q2 2024 to $7.000M in Q1 2025. Gross profit remained healthy with margins at 34% in Q1 2025 compared to 32% in Q2 2024. Operating income hit $357992.00 last quarter, sustaining a consistent 5% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $357992.00. Net income rose to $546524.00, while earnings per share reached $0.005. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan